Abatacept in the Treatment of Uveitis

Completed · Phase 2

Conditions studied: Uveitis

In brief

The purpose of this study is to assess the safety and efficacy of abatacept in the treatment of uveitis.

Key facts

Study ID

NCT01279954

Run by

Oregon Health and Science University

People needed

10

Starts

2012-01-01

Expected to finish

2017-06-01

Last updated by the study team

2019-02-21

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with vision-threatening autoimmune uveitis
• failure to respond to prednisone and at least one other systemic immunosuppressive, or intolerance to such medications due to side effects

You may not qualify if…

• serious concomitant illness that could interfere with the subject's participation

Where it is running

• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.